CDH2 and breast carcinoma: A typical type of EMT in malignant progression involves cadherin switching, which indicates decreased levels of E-cadherin and increased N-cadherin abundance [35]; however, it is reported that EMT does not always accompany decreased E-cadherin in breast cancer [36].